ONO PHARMACEUTICAL CO LTD's ticker is and the CUSIP is 006660107. A total of 1 filers reported holding ONO PHARMACEUTICAL CO LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $824,826,000 | -3.9% | 27,400 | 0.0% | 0.23% | -13.5% |
| Q3 2020 | $857,857,000 | +16.6% | 27,400 | +8.3% | 0.27% | +17.2% |
| Q2 2020 | $735,655,000 | +26.3% | 25,300 | 0.0% | 0.23% | +0.9% |
| Q1 2020 | $582,611,000 | +71.0% | 25,300 | +70.9% | 0.22% | +122.8% |
| Q4 2019 | $340,737,000 | +27.1% | 14,800 | 0.0% | 0.10% | +14.8% |
| Q3 2019 | $267,995,000 | +1.0% | 14,800 | 0.0% | 0.09% | +14.3% |
| Q2 2019 | $265,394,000 | -8.5% | 14,800 | 0.0% | 0.08% | -9.4% |
| Q1 2019 | $290,023,000 | +10.7% | 14,800 | +15.6% | 0.08% | 0.0% |
| Q4 2018 | $261,915,000 | -27.7% | 12,800 | 0.0% | 0.08% | -15.8% |
| Q3 2018 | $362,301,000 | +20.7% | 12,800 | 0.0% | 0.10% | +16.1% |
| Q2 2018 | $300,109,000 | -24.3% | 12,800 | 0.0% | 0.09% | -24.3% |
| Q1 2018 | $396,457,000 | +32.9% | 12,800 | 0.0% | 0.12% | +40.2% |
| Q4 2017 | $298,383,000 | +2.9% | 12,800 | 0.0% | 0.08% | +9.3% |
| Q3 2017 | $289,909,000 | +3.8% | 12,800 | 0.0% | 0.08% | +33.9% |
| Q2 2017 | $279,217,000 | +5.5% | 12,800 | 0.0% | 0.06% | +12.0% |
| Q1 2017 | $264,719,000 | +705.5% | 12,800 | +753.3% | 0.05% | +733.3% |
| Q4 2016 | $32,865,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARADIGM ASSET MANAGEMENT CO LLC | 12,800 | $261,915,000 | 0.08% |